Stay updated with breaking news from Ensol biosciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Korea s small- to mid-sized biotechnology firms are moving to go public on the local stock market despite weak investor sentiment on initial public offerings (IPO) here. Starting with Bioinfra, a local biotech company, which was listed on the secondary Kosdaq on March 2, a group of bio companies here is scheduled to go public, hoping to attract timely investments even as market sentiment has yet to recover. ....
/PRNewswire/ Spine BioPharma, Inc., a biopharmaceutical company committed to developing non-opiate, non-surgical therapies for the treatment of pain and. ....